{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Hema Now: Innovation, Access, and Leadership in Cellular Therapy","description":"In this episode of Hema Now, Megan Melody speaks about the evolution of CAR-T cell therapy and its impact on lymphoma care. She explores the major advances that have transformed outcomes for patients with relapsed and refractory disease, the unanswered questions shaping current research, and the practical challenges of building successful cellular therapy programmes. The conversation also covers equitable access to treatment, the role of quality standards and accreditation, personalised approaches to CAR-T therapy, and the importance of physician leadership and mentorship in shaping the future of academic haematology. Timestamps:   00:00 \u2013 Introduction   01:13 \u2013 Journey into Haematology and Lymphoma   04:19 \u2013 Major Advances in CAR-T   06:00 \u2013 Unanswered Questions After CAR-T   07:45 \u2013 Building Successful Cellular Therapy Programmes   09:06 \u2013 Improving Access to CAR-T   12:55 \u2013 Evolving Standards in Cellular Therapy   14:16 \u2013 Towards Personalised CAR-T Treatment   16:00 \u2013 Physician Leadership in Academic Medicine   17:10 \u2013 Career Advice for Future Specialists   19:02 \u2013 Future Directions in Cellular Therapy  ","author_name":"EMJ Podcast: Insights For Healthcare Professionals","author_url":"http:\/\/emghealthpodcast.libsyn.com\/website","html":"